A detailed history of Ameriprise Financial Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 48,018 shares of RPRX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,018
Previous 44,994 6.72%
Holding current value
$1.17 Million
Previous $1.19 Million 14.5%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$25.63 - $29.27 $77,505 - $88,512
3,024 Added 6.72%
48,018 $1.36 Million
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $3.48 Million - $3.96 Million
-132,364 Reduced 74.63%
44,994 $1.19 Million
Q1 2024

May 15, 2024

BUY
$27.46 - $31.33 $296,732 - $338,551
10,806 Added 6.49%
177,358 $5.39 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $59.5 Million - $66.4 Million
-2,271,500 Reduced 93.17%
166,552 $4.68 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $6.02 Million - $7.19 Million
229,165 Added 10.37%
2,438,052 $66.2 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $21.4 Million - $26.4 Million
723,451 Added 48.7%
2,208,887 $67.9 Million
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $3.22 Million - $3.87 Million
98,288 Added 7.09%
1,485,436 $53.5 Million
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $505,567 - $568,424
12,907 Added 0.94%
1,387,148 $54.8 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $3.37 Million - $3.77 Million
84,542 Added 6.56%
1,374,241 $55.2 Million
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $90,747 - $106,923
-2,418 Reduced 0.19%
1,289,699 $54.2 Million
Q1 2022

May 16, 2022

SELL
$37.46 - $42.44 $320,432 - $363,031
-8,554 Reduced 0.66%
1,292,117 $50.3 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $295,779 - $357,256
8,410 Added 0.65%
1,300,671 $51.8 Million
Q3 2021

Nov 15, 2021

SELL
$36.14 - $42.24 $2.17 Million - $2.53 Million
-59,915 Reduced 4.43%
1,292,261 $46.7 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $3.52 Million - $4.12 Million
88,292 Added 6.99%
1,352,176 $55.4 Million
Q1 2021

May 17, 2021

BUY
$42.34 - $52.82 $20 Million - $24.9 Million
471,201 Added 59.44%
1,263,884 $55.2 Million
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $6.21 Million - $8.61 Million
171,965 Added 27.7%
792,683 $39.7 Million
Q3 2020

Nov 16, 2020

SELL
$38.56 - $48.36 $31 Million - $38.9 Million
-804,652 Reduced 56.45%
620,718 $26.1 Million
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $63.4 Million - $74.3 Million
1,425,370 New
1,425,370 $69.2 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.